Navega Therapeutics

Navega Therapeutics

Biotechnology, High BLF Dr, San Diego, , 92130, California, 12625, United States, 1-10 Employees

navegatx.com

  • LinkedIn

phone no Phone Number: 85********

Who is NAVEGA THERAPEUTICS

Around 1.5 billion people around the world suffer from chronic pain, with more than 100 million in the US alone. Conventional treatment for chronic pain consists mostly of opioid narcotic...

Read More

map
  • 12625 High BLF Dr, San Diego, California, 92130, United States Headquarters: 12625 High BLF Dr, San Diego, California, 92130, United States
  • 2018 Date Founded: 2018
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies
  • Ana Moreno CEO:   Ana Moreno

industries-icon Industry: Biotechnology

SIC SIC Code: 8731

checked-icon Does something look wrong? Fix it. | View contact records from NAVEGA THERAPEUTICS

Navega Therapeutics Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Navega Therapeutics

Answer: Navega Therapeutics's headquarters are located at High BLF Dr, San Diego, , 92130, California, 12625, United States

Answer: Navega Therapeutics's phone number is 85********

Answer: Navega Therapeutics's official website is https://navegatx.com

Answer: Navega Therapeutics's revenue is $1 Million to $5 Million

Answer: Navega Therapeutics's SIC: 8731

Answer: Navega Therapeutics has 1-10 employees

Answer: Navega Therapeutics is in Biotechnology

Answer: Navega Therapeutics contact info: Phone number: 85******** Website: https://navegatx.com

Answer: Around 1.5 billion people around the world suffer from chronic pain, with more than 100 million in the US alone. Conventional treatment for chronic pain consists mostly of opioid narcotics. However, opioids have failed us as the United States is currently undergoing an opioid epidemic. Sadly, over 120 Americans die each day of an opioid overdose. We have developed a patented, non-permanent gene therapy to target pain that is non-addictive, highly specific and long-lasting. So how does this work? We were inspired by nature: there are humans that have a mutation in their genome that feel no pain whatsoever. We have imitated this process by utilizing a novel gene therapy to target pain in a non-permanent way. In our proof of concept, we have demonstrated that the mice that received our therapy have an increased pain tolerance and lower pain levels. Importantly, mice are not numb and can continue feeling mechanical stimulation, such as touch. We believe that patients should not have to decide whether they live a life with pain, or one with the risk of addiction.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access